Table 2.
Overview of clinical parameters and relative serum expression of MMP7, MMP10 and MMP12
Patient Characteristics | N | Median relative serum expression | |||||
---|---|---|---|---|---|---|---|
MMP7 | p | MMP10 | P | MMP12 | p | ||
Gender | 0.049 | 0.138 | 0.004 | ||||
Male | 51 | 1.21 | 1.22 | 1.19 | |||
Female | 24 | 0.97 | 0.95 | 0.88 | |||
Age at operation | 0.013 | 0.003 | 0.253 | ||||
<median = 64 years | 37 | 0.95 | 0.95 | 1.16 | |||
≥ median = 64 years | 38 | 1.2 | 1.36 | 1.03 | |||
T-Stage | 0.582 | 0.957 | 0.481 | ||||
T1 | 2 | 0.86 | 0.9 | 0.42 | |||
T2 | 8 | 0.92 | 1.13 | 1.11 | |||
T3 | 53 | 1.08 | 1.13 | 1.07 | |||
T4 | 13 | 1.24 | 1.22 | 1.19 | |||
N-Stage | 0.806 | 0.074 | 0.301 | ||||
Node negative | 29 | 1.06 | 1.22 | 1.0 | |||
Node positive | 46 | 1.16 | 0.99 | 1.14 | |||
M-Stage | 0.244 | 0.603 | 0.087 | ||||
M0 | 55 | 1.06 | 1.13 | 1.0 | |||
M1 | 23 | 1.26 | 1.13 | 1.19 | |||
L-Stage | 0.629 | 0.085 | 0.593 | ||||
L0 | 61 | 1.06 | 1.18 | 1.06 | |||
L1 | 14 | 1.25 | 0.81 | 1.14 | |||
V-Stage | 0.067 | 0.321 | 0.018 | ||||
V0 | 69 | 1.06 | 1.13 | 1.06 | |||
V1 | 6 | 2.41 | 1.86 | 1.32 | |||
Micro satellite stage | 0.053 | 0.845 | 0.844 | ||||
MSS | 5 | 0.68 | 0.76 | 0.47 | |||
MSI | 2 | 1.16 | 0.95 | 1.01 | |||
Tumor site | <0.001* | 0.76 | 0.758 | ||||
Coecum | 17 | 0.98 | 1.22 | 1.16 | |||
Colon ascendens | 14 | 1.11 | 0.88 | 0.78 | |||
Right colon flexure | 6 | 1.28 | 1.32 | 1.13 | |||
Colon transversum | 3 | 1.37 | 0.86 | 1.0 | |||
Colon descendens | 5 | 2.12 | 2.16 | 1.29 | |||
Colon sigmoideum | 30 | 0.96 | 0.99 | 1.14 |
*In ANOVA p < 0.001, the post-hoc Tukey’s test showed a significant difference between colon descendens and coecum, colon ascendens and right colon flexure (p < 0.001; p < 0.001; p = 0.007, respectively)